Quoted Portfolio Companies
PAION
Unquoted Portfolio Companies
Amura Ltd

Crescendo Biologics

CellCentric Ltd

De Novo Pharmaceuticals

ImmunoBiology Ltd

Medical Device Innovation

Proteom

Purely Proteins
Sold Companies
Paradigm Therapeutics

Cozart plc

Sterix Limited

Cambridge Biotechnology L

Sangamo BioSciences

CeNeS
 
Tuesday, February 7, 2012

12 March 2007 - Takeda to acquire Paradigm Therapeutics. Takeda Pharmaceutical Company Limited today announced that Takeda and Paradigm Therapeutics Limited agreed on March 12th, 2007 to the acquisition of Paradigm by Takeda. 
 
 
Privacy Statement | Sitemap | © 2012 Avlar BioVentures Limited

Avlar BioVentures Limited is authorised and regulated by the Financial Services Authority, who require us to state that investments of this type are only suitable for experienced investors familiar with venture capital and biotechnology companies.